Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.70
+0.08 (1.42%)
At close: Jul 2, 2026, 4:00 PM EDT
5.72
+0.02 (0.35%)
After-hours: Jul 2, 2026, 5:27 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $124.35 million as of July 2, 2026. Its market cap has decreased by -49.14% in one year.
Market Cap
124.35M
Enterprise Value
28.25M
1-Year Change
-49.14%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $124.35M, a decrease of -63.66%. That is a compound annual growth rate of -51.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 124.35M | -56.49% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 132.77M |
| Enlivex | 130.55M |
| Genelux | 128.79M |
| Spero Therapeutics | 128.54M |
| PepGen | 125.20M |
| Fractyl Health | 124.14M |
| Polaryx Therapeutics | 122.15M |
| ProMIS Neurosciences | 120.62M |